RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value: $1.011B (100.0% shares, 0.0% debt)

Holdings (37)

ACHILLION PHARMACEUTICALS INC 12.0%
Value $121M Shares 11,222,893 Est. Cost $6.36 Unrealized
WVE WAVE LIFE SCIENCES LTD 11.2%
Value $113M Shares 7,088,651 Est. Cost $15.68 Unrealized 0.0%
DYAX CORP 10.1%
Value $102M Shares 2,717,618 Est. Cost $10.04 Unrealized
AXOVANT SCIENCES LTD 8.9%
Value $90.15M Shares 5,000,000 Est. Cost $20.38 Unrealized
ACRS ACLARIS THERAPEUTICS INC 6.8%
Value $69.09M Shares 2,564,553 Est. Cost $19.34 Unrealized 0.0%
TGTX TG THERAPEUTICS INC 3.3%
Value $33.57M Shares 2,813,779 Est. Cost $10.99 Unrealized +15.0%
ZOGENIX INC 3.3%
Value $33.21M Shares 2,253,237 Est. Cost $13.82 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 3.2%
Value $31.93M Shares 3,094,064 Est. Cost $9.58 Unrealized +3.8%
ASND ASCENDIS PHARMA A S 3.0%
Value $30.62M Shares 1,671,447 Est. Cost $17.61 Unrealized
REGULUS THERAPEUTICS INC 3.0%
Value $30.37M Shares 3,482,924 Est. Cost $15.20 Unrealized
CHRS COHERUS BIOSCIENCES INC 2.9%
Value $29.21M Shares 1,272,048 Est. Cost $14.11 Unrealized +82.4%
DICERNA PHARMACEUTICALS INC 2.9%
Value $28.83M Shares 2,428,571 Est. Cost $28.25 Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 2.3%
Value $23.59M Shares 857,683 Est. Cost $17.29 Unrealized +21.8%
BLUEPRINT MEDICINES CORP 2.3%
Value $23.14M Shares 878,348 Est. Cost $26.49 Unrealized
PROTEON THERAPEUTICS INC 2.3%
Value $22.91M Shares 1,476,931 Est. Cost $11.67 Unrealized
STRONGBRIDGE BIOPHARMA PLC 2.0%
Value $20.45M Shares 2,690,702 Est. Cost $7.60 Unrealized
AQUINOX PHARMACEUTICALS INC 2.0%
Value $20.22M Shares 1,619,977 Est. Cost $13.98 Unrealized
SGMO SANGAMO BIOSCIENCES INC 2.0%
Value $20.2M Shares 2,212,036 Est. Cost $8.61 Unrealized -10.5%
CIDARA THERAPEUTICS INC 2.0%
Value $20.15M Shares 1,174,219 Est. Cost $13.98 Unrealized
ALCOBRA LTD 1.9%
Value $19.05M Shares 3,032,911 Est. Cost $6.39 Unrealized
ARENA PHARMACEUTICAL S INC 1.6%
Value $16.56M Shares 8,714,482 Est. Cost $1.90 Unrealized
GLOBAL BLOOD THERAPEUTICS INC 1.5%
Value $14.78M Shares 457,142 Est. Cost $42.16 Unrealized
AIMMUNE THERAPEUTICS INC 1.4%
Value $14.58M Shares 790,200 Est. Cost $25.32 Unrealized
DIMENSION THERAPEUTICS INC 1.2%
Value $12.27M Shares 1,087,930 Est. Cost $11.28 Unrealized
ARDX ARDELYX INC 1.0%
Value $10.36M Shares 571,444 Est. Cost $12.61 Unrealized +47.7%
PRONAI THERAPEUTICS INC 0.9%
Value $9.099M Shares 604,982 Est. Cost $20.52 Unrealized
NTRA NATERA INC 0.8%
Value $8.462M Shares 783,520 Est. Cost $16.90 Unrealized -43.7%
TENAX THERAPEUTICS INC 0.8%
Value $7.838M Shares 2,389,700 Est. Cost $3.92 Unrealized
VITAE PHARMACEUTICALS INC 0.6%
Value $5.813M Shares 321,161 Est. Cost $11.01 Unrealized
ZYNERBA PHARMACEUTICALS INC 0.5%
Value $5.107M Shares 507,191 Est. Cost $14.31 Unrealized
APPLIED GENETIC TECHNOL CORP 0.5%
Value $4.816M Shares 236,059 Est. Cost $16.68 Unrealized
NIVALIS THERAPEUTICS INC 0.5%
Value $4.744M Shares 612,863 Est. Cost $15.15 Unrealized
AKARI THERAPEUTICS PLC 0.4%
Value $3.827M Shares 263,921 Est. Cost $24.00 Unrealized
ARCA BIOPHARMA INC 0.4%
Value $3.619M Shares 778,211 Est. Cost $4.96 Unrealized
DERMA SCIENCES INC 0.3%
Value $2.93M Shares 641,236 Est. Cost $4.57 Unrealized
NEURODERM LTD 0.2%
Value $2.467M Shares 144,671 Est. Cost $20.67 Unrealized
AMPLIPHI BIOSCIENCES CORP 0.0%
Value $213K Shares 53,600 Est. Cost $3.95 Unrealized